Vimarsana
Biggest News Aggregation in the World

Page 5 - Thomas Theuringer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Thomas Theuringer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Thomas Theuringer Today - Breaking & Trending Today

FBI approves QIAGEN's NGS-based ForenSeq MainstAY workflow for the U.S. National DNA Index System (NDIS) - Qiagen (NYSE:QGEN) - Vimarsana News

FBI approves QIAGEN's NGS-based ForenSeq MainstAY workflow for the U.S. National DNA Index System (NDIS) - Qiagen (NYSE:QGEN)

Venlo, the Netherlands, and San Diego, California, June 20, 2023 (GLOBE NEWSWIRE) -- QIAGEN (NYSE:QGEN, Frankfurt Prime Standard: QIA)) announced today that the U.S. Federal Bureau of Investigation (FBI) has approved

FBI approves QIAGEN's NGS-based ForenSeq MainstAY workflow for the U.S. National DNA Index System (NDIS) - Vimarsana News

FBI approves QIAGEN's NGS-based ForenSeq MainstAY workflow for the U.S. National DNA Index System (NDIS)

NDIS approval provides access to federal government funding for accredited public crime laboratories in the U.S. to implement next-generation sequencing for routine casework // NGS-based ForenSeq... | June 20, 2023

QIAGEN's QuantiFERON-TB Gold Plus shows unique clinical value with CD8 technology in new meta-analysis of tuberculosis screening - Vimarsana News

QIAGEN's QuantiFERON-TB Gold Plus shows unique clinical value with CD8 technology in new meta-analysis of tuberculosis screening

Venlo, the Netherlands, June 15, 2023 -- QIAGEN welcomes the publication of a new, systematic review highlighting the unique value of its proprietary tuberculosis testing technology. The study... | June 15, 2023

Danish National Genome Center selects QIAGEN for variant interpretation in oncology genome sequencing - Qiagen (NYSE:QGEN) - Vimarsana News

Danish National Genome Center selects QIAGEN for variant interpretation in oncology genome sequencing - Qiagen (NYSE:QGEN)

Venlo, the Netherlands, and Redwood City, California, June 13, 2023 (GLOBE NEWSWIRE) -- QIAGEN (NYSE:QGEN, Frankfurt Prime Standard: QIA)) today announced that its variant interpretation and reporting software, QIAGEN

QIAGEN launches QIAstat-Dx in Japan with respiratory panel for syndromic testing - Vimarsana News

QIAGEN launches QIAstat-Dx in Japan with respiratory panel for syndromic testing

Venlo, the Netherlands, April 24, 2023 -- QIAGEN announced today that its QIAstat-Dx syndromic testing solution is expected to be available soon for use in Japan with a SARS-CoV-2 Respiratory... | April 24, 2023